DBVT FY 2012 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$494M

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$230,592+41.1% YoY

Gross Profit

$120,87952.4% margin

Operating Income

-$18M-7664.2% margin

Net Income

-$17M-7382.7% margin

EPS (Diluted)

$-6.35

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$73M

Total Liabilities

$6M

Stockholders' Equity

$67M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$230,592	$163,373	+41.1%
Gross Profit	$120,879	-$63,567	+290.2%
Operating Income	-$18M	-$9M	-87.8%
Net Income	-$17M	-$9M	-81.4%